These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3244464)

  • 1. [Carteolol in the treatment of open-angle glaucoma].
    Gorgone G; Randazzo S; Spina F
    Ophtalmologie; 1988; 2(5):431-3. PubMed ID: 3244464
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pilocarpine, carbachol and carteolol on open-angle glaucoma and ocular hypertension (author's transl)].
    Ishikawa T; Okisaka S; Hiwatari S; Taketani P; Sugimachi Y
    Nippon Ganka Gakkai Zasshi; 1981; 85(7):837-42. PubMed ID: 7304355
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carteolol: general practice-oriented assessment of the effectiveness and tolerance of a new beta-blocker in the treatment of glaucoma].
    Schnaudigel OE; Becker H; Fuchs HB
    Klin Monbl Augenheilkd; 1988 Mar; 192(3):248-51. PubMed ID: 3374015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops].
    Flury H; Tournoux A; Martenet AC
    Klin Monbl Augenheilkd; 1986 Jun; 188(6):573-5. PubMed ID: 3761959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)].
    Kitazawa Y; Azuma I; Takase M; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1981; 85(7):798-804. PubMed ID: 7030018
    [No Abstract]   [Full Text] [Related]  

  • 6. [1% carteolol hydrochloride eyedrops: long-term experience in the treatment of chronic open-angle glaucoma].
    van Husen H
    Klin Monbl Augenheilkd; 1986 Dec; 189(6):491-5. PubMed ID: 3550260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latanoprost therapy in patients with glaucoma and ocular hypertension inadequately controlled with carteolol.
    Yasar T; Ozdemir M; Andi I; Ozdemir G; Simsek S
    Jpn J Ophthalmol; 2004; 48(2):172-3. PubMed ID: 15060799
    [No Abstract]   [Full Text] [Related]  

  • 8. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)].
    Negishi C; Ueda S; Kanai A; Nakajima A; Funahashi M; Kitazawa Y; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1981 Jan; 85(1):57-66. PubMed ID: 6114632
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of glaucoma with atenolol eye drops.
    Dhir SP; Sharma PL; Jain IS
    Indian J Ophthalmol; 1981 Oct; 29(3):229-33. PubMed ID: 7346433
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypotensive effect of carteolol on intraocular pressure elevation and secondary glaucoma associated with endogenous uveitis.
    Ohno S; Ichiishi A; Matsuda H
    Ophthalmologica; 1989; 199(1):41-5. PubMed ID: 2761985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long term clinical trial of carteolol in the management of glaucoma. Belgian Carteolol Study Participants.
    Vercruysse K; Goethals M; Vandeputte O; Missotten L
    Bull Soc Belge Ophtalmol; 1992; 245():75-80. PubMed ID: 1344751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of the use of Thymoptik (timolol) in the treatment of primary glaucoma].
    Ermakova VN
    Vestn Oftalmol; 1981; (5):10-3. PubMed ID: 7303348
    [No Abstract]   [Full Text] [Related]  

  • 14. [Initial experience with the beta-blocker befunolol in the treatment of open-angle glaucoma in Europe].
    Merté HJ; Stryz JR
    Klin Monbl Augenheilkd; 1984 Jan; 184(1):55-8. PubMed ID: 6142975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
    J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carteolol: preliminary study on ocular pressure-reducing action.
    Gorgone G; Spina F; Amantia L
    Ophthalmologica; 1983; 187(3):171-3. PubMed ID: 6355953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 12-hour control of intraocular pressure on carteolol 2% twice daily.
    Duff GR; Newcombe RG
    Br J Ophthalmol; 1988 Dec; 72(12):890-1. PubMed ID: 3067744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
    Werning C
    Arzneimittelforschung; 1983; 33(2a):325-30. PubMed ID: 6682324
    [No Abstract]   [Full Text] [Related]  

  • 19. Allergic contact dermatitis from carteolol and timolol in eyedrops.
    Quiralte J; Florido F; de San Pedro BS
    Contact Dermatitis; 2000 Apr; 42(4):245. PubMed ID: 10750865
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of essential hypertension with the beta-receptor antagonist carteolol. A multicenter study].
    Rosprich G; Sölter H
    Arzneimittelforschung; 1983; 33(2a):334-9. PubMed ID: 6682326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.